Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
---|---|
Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
ClinicalTrials.gov Identifier: | NCT00090389 |
The purpose of this study is to evaluate the safety and effectiveness of acupuncture in treating women's health conditions.
Condition | Intervention | Phase |
---|---|---|
Ovarian Neoplasms Endometriosis Pelvic Pain Uterine Neoplasms |
Procedure: Chinese Acupuncture |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | New England School of Acupuncture (NESA) Acupuncture Research Collaborative |
Estimated Enrollment: | 50 |
Study Start Date: | January 2005 |
Study Completion Date: | May 2007 |
Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |
This trial comprises three studies. In the first two studies, women will be randomly assigned to receive either real or sham acupuncture therapy. Study 1 will include women with various forms of cancer. White blood cell counts will be used to assess the effects of acupuncture on participants' immune responses. Study 2 will include women with unspecified pelvic pain and endometriosis; a self-report pain scale will be used to assess the effects of acupuncture on participants' symptoms. Study 3 will evaluate the validity and reliability of diagnoses made by Chinese medicine practitioners. In this study, a group of Chinese medicine practitioners will diagnose the same group of patients; consistency of the diagnoses will be evaluated.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria for Study 1:
Inclusion Criteria for Study 2:
Currently closed to recruitment
Exclusion Criteria for Studies 1 and 2:
United States, Massachusetts | |
Dana Farber Cancer Institute | |
Boston, Massachusetts, United States, 02115 |
Principal Investigator: | Peter Wayne, PhD | New England School of Acupuncture |
Study ID Numbers: | U19 AT002022 |
Study First Received: | August 25, 2004 |
Last Updated: | January 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00090389 |
Health Authority: | United States: Federal Government |
Acupuncture Medicine, Chinese Traditional |
Ovarian cancer Ovarian Neoplasms Gonadal Disorders Genital Neoplasms, Female Uterine Diseases Endocrine System Diseases Pain Endometriosis |
Urogenital Neoplasms Ovarian Diseases Genital Diseases, Female Signs and Symptoms Pelvic Pain Uterine Neoplasms Endocrinopathy Endocrine Gland Neoplasms |
Neoplasms Neoplasms by Site Adnexal Diseases |